BGB Rejects Natraceutical Call

Mar 9, 2011

Bio Group Brazil (BGB) says it has rejected a call option on a 46.8% stake in Natraceutical, valued at EUR66m. BGB received...

To continue reading please take a free trial, subscribe or login below.

Already have an account?


Subscribe now for unlimited access to all current and archive news, data and market analysis. 


Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

LatinFinance Events


Which area will be most profitable for investment banks in LatAm in 2016?